While most foods act indirectly, alfalfa is one of the few that has a direct triggering mechanism. This plant, often found in “health” salads, vegetarian sandwiches or certain food supplements, contains L-canavanine. This is a non-protein amino acid that is structurally similar to arginine. The body mistakenly incorporates it into its own proteins, thereby altering their structure. The immune system, no longer recognising these modified proteins, launches a massive attack against its own tissues. In a patient with lupus, consumption of alfalfa sprouts or mung bean sprouts can worsen autoantibody activity. It is essential to avoid these foods, as clinical observations have shown that they can reactivate native anti-DNA antibodies and trigger severe joint pain, even during a phase of stable remission.
While alfalfa is contraindicated in patients with lupus because it contains L-canavanine, garlic (Allium sativum), by contrast, should be avoided for the opposite reason: its stimulating effect on the immune system is too strong. Garlic contains sulphur compounds, notably allicin and thiosulphates, which have powerful immunostimulant properties. In a healthy person, these molecules strengthen natural defences, but in a patient with lupus they exacerbate the imbalance of the immune system. By stimulating the activity of macrophages and T lymphocytes, garlic increases the production of autoantibodies and can turn a stable phase into an acute inflammatory flare.
This vigilance extends beyond fresh garlic cloves: garlic powder and garlic extracts found in ready-made dishes and so‑called “detox” food supplements are also affected.
In a similar vein to garlic, echinacea is a medicinal plant whose natural reputation conceals a danger for patients with lupus. Often consumed as herbal teas, capsules or mother tinctures to prevent colds, it acts by increasing the production of pro-inflammatory cytokines (TNF-α, IFN-γ). Clinical observations have shown that echinacea can not only interfere with immunosuppressive treatments by cancelling out their effects, but also trigger a resumption of autoimmune activity in patients who were previously stable. By driving lymphocytes to multiply, it risks disrupting the patient’s fragile immune tolerance and precipitating the body into a new flare.